Trade LYCA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Lycia Therapeutics, Inc. (LYCA) is trading at US$31.77, up 1.34% today as of Nov 19, 16:00 EST. The company has a market capitalisation of US$1.76B. Over the past 52 weeks, LYCA has traded between US$18.00 and US$36.49. On Syfe you can trade LYCA with $0 commission and add it to your watchlist.
| Previous close | US$31.35 |
|---|---|
| Market cap | US$1.76B |
| 52-week range | US$18.00 – US$36.49 |
| Volume | 281.79K |
| Exchange | US |
Lycia Therapeutics, Inc.
Lycia Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory, and allergic diseases. The company was founded in 2019 and is headquartered in South San Francisco, CA.
Lycia Therapeutics, Inc. (LYCA) stock is trading at US$31.77, +1.34% from the previous close of US$31.35.
The market cap for Lycia Therapeutics, Inc. (LYCA) stock is approximately US$1.76B.
The 52-week high for Lycia Therapeutics, Inc. (LYCA) stock is US$36.49.
The 52-week low for Lycia Therapeutics, Inc. (LYCA) stock is US$18.00.
Lycia Therapeutics, Inc. (LYCA) does not currently pay a dividend.
Stay on top of LYCA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore